Browse By: Country ι Category ι Tag
Home  »  Head and Neck Cancer

Head and Neck Cancer Market Research Reports

More

Tykerb (Head and Neck Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Tykerb(Head and Neck Cancer )-Analysis and Forecasts to 2020 provides Zelapar sales forecast the forecast period (2014-2020). The report also includes information on Head and Neck Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase. Scope Therapy area profile including patient population for the
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Reolysin (Head and Neck Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Reolysin(Head and Neck Cancer )-Analysis and Forecasts to 2020 provides Reolysin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Head and Neck Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Note:
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Methotrexate (Head and Neck Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Methotrexate (Head and Neck Cancer )-Analysis and Forecasts to 2020 provides Methotrexate sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Head and Neck Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. N
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Bleomycin (Head and Neck Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Bleomycin (Head and Neck Cancer) Analysis and Forecasts to 2020 provides Bleomycin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Head and Neck Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Note: Th
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Iressa (Head and Neck Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Iressa (Head and Neck Cancer) Analysis and Forecasts to 2020 provides Iressa ERsales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Parkinson\'s Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts. Note: This is a on-d
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (Head and Neck Cancer) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Avastin (Head and Neck Cancer) Analysis and Forecasts to 2020 provides Avastin sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Head and Neck Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a on-d
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Cisplatin (Head and Neck Cancer) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Cisplatin (Head and Neck Cancer) Analysis and Forecasts to 2020 provides Cisplatin sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Head and Neck Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Erbitux (Head and Neck Cancer) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Erbitux (Head and Neck cancer)- Analysis and Forecasts to 2020 provides Erbitux sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2006-2020). The report also includes information on Head and Neck cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a on-
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Nimotuzumab (Head and Neck Cancer) - Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Nimotuzumab (Head and Neck Cancer) - Analysis and Forecasts to 2020 provides Nimotuzumab sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Head and Neck cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.&nb
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Taxotere (Head and Neck Cancer) Analysis and Forecasts to 2017
SummaryGlobalDatas pharmaceuticals report, Taxotere (Head and Neck cancer)- Analysis and Forecasts to 2017 provides Taxotere sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2017). The report also includes information on Renal Cell Carcinoma market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Back To Top